186 related articles for article (PubMed ID: 25860612)
1. KPC1-mediated ubiquitination and proteasomal processing of NF-κB1 p105 to p50 restricts tumor growth.
Kravtsova-Ivantsiv Y; Shomer I; Cohen-Kaplan V; Snijder B; Superti-Furga G; Gonen H; Sommer T; Ziv T; Admon A; Naroditsky I; Jbara M; Brik A; Pikarsky E; Kwon YT; Doweck I; Ciechanover A
Cell; 2015 Apr; 161(2):333-47. PubMed ID: 25860612
[TBL] [Abstract][Full Text] [Related]
2. A short binding site in the KPC1 ubiquitin ligase mediates processing of NF-κB1 p105 to p50: A potential for a tumor-suppressive PROTAC.
Goldhirsh G; Kravtsova-Ivantsiv Y; Satish G; Ziv T; Brik A; Ciechanover A
Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34873064
[TBL] [Abstract][Full Text] [Related]
3. The p105 NF-ĸB precursor is a pseudo substrate of the ubiquitin ligase FBXO7, and its binding to the ligase stabilizes it and results in stimulated cell proliferation.
Udasin RG; Gottfried Y; Fabre B; Bercovich B; Ziv T; Ciechanover A
Biochem Biophys Res Commun; 2021 Jun; 558():224-230. PubMed ID: 32933748
[TBL] [Abstract][Full Text] [Related]
4. Excess of the NF-ĸB p50 subunit generated by the ubiquitin ligase KPC1 suppresses tumors via PD-L1- and chemokines-mediated mechanisms.
Kravtsova-Ivantsiv Y; Goldhirsh G; Ivantsiv A; Ben Itzhak O; Kwon YT; Pikarsky E; Ciechanover A
Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29823-29831. PubMed ID: 33168738
[TBL] [Abstract][Full Text] [Related]
5. A20 inhibits both the degradation and limited processing of the NF-κB p105 precursor: A novel additional layer to its regulator role.
Lapid D; Lahav-Baratz S; Cohen S
Biochem Biophys Res Commun; 2017 Nov; 493(1):52-57. PubMed ID: 28923245
[TBL] [Abstract][Full Text] [Related]
6. The NF-ĸB p50 subunit generated by KPC1-mediated ubiquitination and limited proteasomal processing, suppresses tumor growth.
Kravtsova-Ivantsiv Y; Goldhirsh G; Tomuleasa C; Pikarsky E; Ciechanover A
Cancer Cell Int; 2023 Apr; 23(1):67. PubMed ID: 37055826
[TBL] [Abstract][Full Text] [Related]
7. The Tumor Suppressor Functions of Ubiquitin Ligase KPC1: From Cell-Cycle Control to NF-κB Regulator.
Gulei D; Drula R; Ghiaur G; Buzoianu AD; Kravtsova-Ivantsiv Y; Tomuleasa C; Ciechanover A
Cancer Res; 2023 Jun; 83(11):1762-1767. PubMed ID: 36880841
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin-proteasome system and activation of NF-κB: involvement of the ubiquitin ligase KPC1 in p105 processing and tumor suppression.
Kravtsova-Ivantsiv Y; Ciechanover A
Mol Cell Oncol; 2015; 2(4):e1054552. PubMed ID: 27308511
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin ligase TRUSS augments the expression of interleukin-10 via proteasomal processing of NF-κB1/p105 to NF-κB/p50.
Jamal A; Husein A; Bihari C; Kumar V
Cell Signal; 2020 Nov; 75():109766. PubMed ID: 32889079
[TBL] [Abstract][Full Text] [Related]
10. Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-kappaB precursor.
Kravtsova-Ivantsiv Y; Cohen S; Ciechanover A
Mol Cell; 2009 Feb; 33(4):496-504. PubMed ID: 19250910
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of ubiquitin-mediated, limited processing of the NF-kappaB1 precursor protein p105.
Ciechanover A; Gonen H; Bercovich B; Cohen S; Fajerman I; Israël A; Mercurio F; Kahana C; Schwartz AL; Iwai K; Orian A
Biochimie; 2001; 83(3-4):341-9. PubMed ID: 11295495
[TBL] [Abstract][Full Text] [Related]
12. The 20S proteasome processes NF-kappaB1 p105 into p50 in a translation-independent manner.
Moorthy AK; Savinova OV; Ho JQ; Wang VY; Vu D; Ghosh G
EMBO J; 2006 May; 25(9):1945-56. PubMed ID: 16619030
[TBL] [Abstract][Full Text] [Related]
13. Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-κB precursor.
Kravtsova-Ivantsiv Y; Cohen S; Ciechanover A
Adv Exp Med Biol; 2011; 691():95-106. PubMed ID: 21153313
[No Abstract] [Full Text] [Related]
14. Processing of p105 is inhibited by docking of p50 active subunits to the ankyrin repeat domain, and inhibition is alleviated by signaling via the carboxyl-terminal phosphorylation/ ubiquitin-ligase binding domain.
Cohen S; Orian A; Ciechanover A
J Biol Chem; 2001 Jul; 276(29):26769-76. PubMed ID: 11350967
[TBL] [Abstract][Full Text] [Related]
15. The A-to-I editing of KPC1 promotes intrahepatic cholangiocarcinoma by attenuating proteasomal processing of NF-κB1 p105 to p50.
Gao C; Zhou G; Shi J; Shi P; Jin L; Li Y; Wang X; Liao S; Yan H; Wu J; Lu Y; Zhai Y; Zhang J; Zhang H; Zhang H; Yang C; Cao P; Cheng S; Zhou G
J Exp Clin Cancer Res; 2022 Dec; 41(1):338. PubMed ID: 36476255
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-κB Pathway in Melanoma.
Iida Y; Ciechanover A; Marzese DM; Hata K; Bustos M; Ono S; Wang J; Salomon MP; Tran K; Lam S; Hsu S; Nelson N; Kravtsova-Ivantsiv Y; Mills GB; Davies MA; Hoon DSB
Clin Cancer Res; 2017 Aug; 23(16):4831-4842. PubMed ID: 28389511
[No Abstract] [Full Text] [Related]
17. Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha.
Heissmeyer V; Krappmann D; Hatada EN; Scheidereit C
Mol Cell Biol; 2001 Feb; 21(4):1024-35. PubMed ID: 11158290
[TBL] [Abstract][Full Text] [Related]
18. Two distinct ubiquitin-dependent mechanisms are involved in NF-kappaB p105 proteolysis.
Cohen S; Lahav-Baratz S; Ciechanover A
Biochem Biophys Res Commun; 2006 Jun; 345(1):7-13. PubMed ID: 16678126
[TBL] [Abstract][Full Text] [Related]
19. NFKB1: a suppressor of inflammation, ageing and cancer.
Cartwright T; Perkins ND; L Wilson C
FEBS J; 2016 May; 283(10):1812-22. PubMed ID: 26663363
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-mediated processing of NF-kappa B transcriptional activator precursor p105. Reconstitution of a cell-free system and identification of the ubiquitin-carrier protein, E2, and a novel ubiquitin-protein ligase, E3, involved in conjugation.
Orian A; Whiteside S; Israël A; Stancovski I; Schwartz AL; Ciechanover A
J Biol Chem; 1995 Sep; 270(37):21707-14. PubMed ID: 7665588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
